Deferred Royalty Obligation related to the Sale of Future Royalties - Schedule of Royalty Obligation transaction (Details) $ in Thousands |
6 Months Ended |
|---|---|
|
Jun. 30, 2023
USD ($)
| |
| Deferred Royalty Obligation [Line Items] | |
| Deferred royalty obligation related to the sale of future Vaxcyte royalties, net | $ 136,653 |
| Vaxcyte, Inc. | |
| Deferred Royalty Obligation [Line Items] | |
| Proceeds from sale of future Vaxcyte royalties | 140,000 |
| Issuance costs | (3,792) |
| Non-cash interest expense associated with the sale of future Vaxcyte royalties | 442 |
| Amortization of issuance costs | 3 |
| Deferred royalty obligation related to the sale of future Vaxcyte royalties, net | $ 136,653 |
| X | ||||||||||
- Definition Amortization of issuance costs. No definition available.
|
| X | ||||||||||
- Definition Deferred royalty obligation. No definition available.
|
| X | ||||||||||
- Definition Deferred royalty obligation related to the sale of future royalties, classified as noncurrent. No definition available.
|
| X | ||||||||||
- Definition Non cash interest expense associated with the sale of future royalties No definition available.
|
| X | ||||||||||
- Definition Proceeds from sale of future royalties No definition available.
|
| X | ||||||||||
- Definition Royality Issuance costs. No definition available.
|
| X | ||||||||||
- Details
|